BACKGROUND: Bariatric surgery is currently the most efficacious treatment for obesity and its associated metabolic co-morbidities, such as diabetes. The metabolic improvements occur through both weight-dependent and weight-independent mechanisms. Bile acids (BAs) have emerged as key signalling molecules that have a central role in modulating many of the physiological effects seen after bariatric surgery. This systematic review assesses the evidence from both human and animal studies for the role of BAs in reducing the metabolic complications of obesity following bariatric surgery. METHODS: We conducted a systematic search of Medline and Embase databases to identify all articles investigating the role of BAs in mediating the metabolic changes observed following bariatric surgery in both animal and human studies. Boolean logic was used with relevant search terms, including the following MeSH terms: 'bile acids and salts', 'bariatric surgery', 'metabolic surgery', 'gastrointestinal tract/surgery' and 'obesity/surgery'. RESULTS: Following database searches (n=1197), inclusion from bibliography searches (n=2) and de-duplication (n=197), 1002 search results were returned. Of these, 132 articles were selected for full-text review, of which 38 articles were deemed relevant and included in the review. The findings support the effects of BAs on satiety, lipid and cholesterol metabolism, incretins and glucose homoeostasis, energy metabolism, gut microbiota and endoplasmic reticulum stress following bariatric surgery. Many of these metabolic effects are modulated through the BA receptors FXR and TGR5. We also explore a possible link between BAs and carcinogenesis following bariatric surgery. CONCLUSIONS: Overall there is good evidence to support the role of BAs in the metabolic effects of bariatric surgery through the above mechanisms. BAs could serve as a novel therapeutic pharmacological target for the treatment of obesity and its associated co-morbidities.
BACKGROUND: Bariatric surgery is currently the most efficacious treatment for obesity and its associated metabolic co-morbidities, such as diabetes. The metabolic improvements occur through both weight-dependent and weight-independent mechanisms. Bile acids (BAs) have emerged as key signalling molecules that have a central role in modulating many of the physiological effects seen after bariatric surgery. This systematic review assesses the evidence from both human and animal studies for the role of BAs in reducing the metabolic complications of obesity following bariatric surgery. METHODS: We conducted a systematic search of Medline and Embase databases to identify all articles investigating the role of BAs in mediating the metabolic changes observed following bariatric surgery in both animal and human studies. Boolean logic was used with relevant search terms, including the following MeSH terms: 'bile acids and salts', 'bariatric surgery', 'metabolic surgery', 'gastrointestinal tract/surgery' and 'obesity/surgery'. RESULTS: Following database searches (n=1197), inclusion from bibliography searches (n=2) and de-duplication (n=197), 1002 search results were returned. Of these, 132 articles were selected for full-text review, of which 38 articles were deemed relevant and included in the review. The findings support the effects of BAs on satiety, lipid and cholesterol metabolism, incretins and glucose homoeostasis, energy metabolism, gut microbiota and endoplasmic reticulum stress following bariatric surgery. Many of these metabolic effects are modulated through the BA receptors FXR and TGR5. We also explore a possible link between BAs and carcinogenesis following bariatric surgery. CONCLUSIONS: Overall there is good evidence to support the role of BAs in the metabolic effects of bariatric surgery through the above mechanisms. BAs could serve as a novel therapeutic pharmacological target for the treatment of obesity and its associated co-morbidities.
Authors: Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil Journal: Science Date: 2006-08-25 Impact factor: 47.728
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245
Authors: Marco Milone; Roberta Lupoli; Paola Maietta; Alessandro Di Minno; Paolo Bianco; Pasquale Ambrosino; Guido Coretti; Francesco Milone; Matteo Nicola Dario Di Minno; Mario Musella Journal: Int J Surg Date: 2015-01-07 Impact factor: 6.071
Authors: E Griffo; G Nosso; R Lupoli; M Cotugno; G Saldalamacchia; G Vitolo; L Angrisani; P P Cutolo; A A Rivellese; B Capaldo Journal: Obes Surg Date: 2014-05 Impact factor: 4.129
Authors: Samantha Scholtz; Alexander D Miras; Navpreet Chhina; Christina G Prechtl; Michelle L Sleeth; Norlida M Daud; Nurhafzan A Ismail; Giuliana Durighel; Ahmed R Ahmed; Torsten Olbers; Royce P Vincent; Jamshid Alaghband-Zadeh; Mohammad A Ghatei; Adam D Waldman; Gary S Frost; Jimmy D Bell; Carel W le Roux; Anthony P Goldstone Journal: Gut Date: 2013-08-20 Impact factor: 31.793
Authors: Huijuan Ma; Vicencia M Sales; Ashley R Wolf; Sathish Subramanian; Tucker J Matthews; Michael Chen; Aparna Sharma; Walt Gall; Wim Kulik; David E Cohen; Yusuke Adachi; Nicholas W Griffin; Jeffrey I Gordon; Mary-Elizabeth Patti; Elvira Isganaitis Journal: Endocrinology Date: 2017-08-01 Impact factor: 4.736
Authors: Federico Marchesi; Francesco Tartamella; Giuseppina De Sario; Clarissa Forlini; Alberta Caleffi; Matteo Riccò; Francesco Di Mario Journal: Obes Surg Date: 2017-07 Impact factor: 4.129
Authors: O Chávez-Talavera; G Baud; V Spinelli; M Daoudi; M Kouach; J-F Goossens; E Vallez; R Caiazzo; M Ghunaim; T Hubert; S Lestavel; A Tailleux; B Staels; F Pattou Journal: Int J Obes (Lond) Date: 2017-01-17 Impact factor: 5.095
Authors: Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary Journal: Physiol Rev Date: 2017-01 Impact factor: 37.312
Authors: Noora Kanerva; Ingrid Larsson; Markku Peltonen; Anna-Karin Lindroos; Lena M Carlsson Journal: Am J Clin Nutr Date: 2017-05-17 Impact factor: 7.045